Search research articles
Contact Us
Filters
Showing results (71-80 of 117) with videos related to
Page
of 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2015
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples
Boris Winterhoff, Luisa Freyer, Edward Hammond, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 14, 2016
A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome
Aminah Jatoi, Megan E Grudem, Travis J Dockter, et al.
Mayo Clinic Proceedings
|
February 1, 2016
Recurrence and Survival Outcomes After Percutaneous Thermal Ablation of Oligometastatic Melanoma
Mariah L White, Thomas D Atwell, A Nicholas Kurup, et al.
Annals of Surgical Oncology
|
May 30, 2026
Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy
Tina J Hieken, Thomas J Flotte, David Zahrieh, et al.
Annals of Surgical Oncology
|
June 17, 2026
ASO Visual Abstract: Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma-Results from the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy
Tina J Hieken, Thomas J Flotte, David Zahrieh, et al.
British Journal of Cancer
|
June 3, 2016
Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer
Chen Wang, Boris J Winterhoff, Kimberly R Kalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2018
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients
Kimberly R Kalli, Matthew S Block, Pashtoon M Kasi, et al.
JCI Insight
|
May 17, 2016
T cell Bim levels reflect responses to anti-PD-1 cancer therapy
Roxana S Dronca, Xin Liu, Susan M Harrington, et al.
Journal for Immunotherapy of Cancer
|
November 2, 2023
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade
Yan Luo, Barath Shreeder, James W Jenkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 117) with videos related to
Sort By:
Page
of 12
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2015
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples
Boris Winterhoff, Luisa Freyer, Edward Hammond, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 14, 2016
A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome
Aminah Jatoi, Megan E Grudem, Travis J Dockter, et al.
Mayo Clinic Proceedings
|
February 1, 2016
Recurrence and Survival Outcomes After Percutaneous Thermal Ablation of Oligometastatic Melanoma
Mariah L White, Thomas D Atwell, A Nicholas Kurup, et al.
Annals of Surgical Oncology
|
May 30, 2026
Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy
Tina J Hieken, Thomas J Flotte, David Zahrieh, et al.
Annals of Surgical Oncology
|
June 17, 2026
ASO Visual Abstract: Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma-Results from the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy
Tina J Hieken, Thomas J Flotte, David Zahrieh, et al.
British Journal of Cancer
|
June 3, 2016
Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer
Chen Wang, Boris J Winterhoff, Kimberly R Kalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2018
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients
Kimberly R Kalli, Matthew S Block, Pashtoon M Kasi, et al.
JCI Insight
|
May 17, 2016
T cell Bim levels reflect responses to anti-PD-1 cancer therapy
Roxana S Dronca, Xin Liu, Susan M Harrington, et al.
Journal for Immunotherapy of Cancer
|
November 2, 2023
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade
Yan Luo, Barath Shreeder, James W Jenkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Page
of 12